Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncAMP response element binding

NR4A3 TCF12

5.04e-0512182GO:0035497
Pubmed

The kappaB and V(D)J recombination signal sequence binding protein KRC regulates transcription of the mouse metastasis-associated gene S100A4/mts1.

HIVEP3 TCF12

7.59e-07318210625627
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

ZNF462 UBR4 TCF12

3.93e-0428218323667531
Pubmed

Toward a complete human genome sequence.

RAB6D RAB6C TNS3 PRKAG2

4.52e-047241849847074
InteractionLIPT2 interactions

ST14 UBR4

3.38e-0510182int:LIPT2
Cytoband2q21.1

RAB6D RAB6C

2.37e-04581822q21.1
CytobandEnsembl 112 genes in cytogenetic band chr9q31

ZNF462 NR4A3

1.31e-03137182chr9q31
CytobandEnsembl 112 genes in cytogenetic band chr2q21

RAB6D RAB6C

1.59e-03151182chr2q21
CoexpressionTRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL

HIVEP3 AMPD3 TNS3 SBNO2 UBR4

1.01e-04724185M41700
CoexpressionGSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP

HIVEP3 NR4A3 TNS3

1.49e-04153183M8249
CoexpressionGSE21033_1H_VS_24H_POLYIC_STIM_DC_UP

AGFG2 HIVEP3 TCF12

1.73e-04161183M7728
CoexpressionVALK_AML_CLUSTER_15

TNS3 ATN1

2.05e-0431182M15545
CoexpressionGSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP

AGFG2 AMPD3 PRKAG2

2.45e-04181183M6849
CoexpressionGSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP

CPEB2 AMPD3 SBNO2

2.49e-04182183M7624
CoexpressionVALK_AML_WITH_CEBPA

TNS3 ATN1

2.92e-0437182M19586
CoexpressionGSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN

CPEB2 AGFG2 NR4A3

3.14e-04197183M3344
CoexpressionGSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN

AGFG2 HIVEP3 TCF12

3.19e-04198183M4554
CoexpressionGSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP

AMPD3 TNS3 UBR4

3.19e-04198183M6123
CoexpressionGSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN

AGFG2 ST14 TNS3

3.28e-04200183M9482
CoexpressionGSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP

AMPD3 TNS3 PRKAG2

3.28e-04200183M8567
CoexpressionGSE2585_CTEC_VS_THYMIC_DC_UP

ST14 TNS3 NOBOX

3.28e-04200183M6271
CoexpressionGSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN

HIVEP3 AMPD3 PRKAG2

3.28e-04200183M3260
CoexpressionGSE3982_DC_VS_NKCELL_UP

HIVEP3 NR4A3 AMPD3

3.28e-04200183M5478
CoexpressionGSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN

HIVEP3 TCF12 PRKAG2

3.28e-04200183M7992
CoexpressionGSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN

HIVEP3 ST14 TNS3

3.28e-04200183M3199
CoexpressionGSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN

NR4A3 SBNO2 ATN1

3.28e-04200183M5156
CoexpressionZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF

CPEB2 NR4A3 SBNO2

5.06e-04232183M2613
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAB6D AGFG2 AMPD3 RAB6C

5.13e-07165184b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAB6D AGFG2 AMPD3 RAB6C

5.13e-0716518428f8297ec7b781149cc7ac2f5e441771083b8ee3
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HIVEP3 NR4A3 AMPD3

3.46e-051601835d8d97c3da5837ba5fe743d2f8438f5cb7cea64b
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZNF462 AGFG2 NR4A3

4.08e-05169183e3410ccb3f85811c75694e286115803911169a2f
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF462 AGFG2 NR4A3

4.08e-05169183a4f610d07c3ba5537f4497f523669b914f7eddc1
ToppCellmedial-2-Hematologic-Myeloid_Dendritic_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RAB6D NR4A3 ST14

6.24e-0519518354a404ee1b97d0659fcffafb20d11f878ed453d4
ToppCellmedial-Hematologic-Myeloid_Dendritic_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RAB6D NR4A3 ST14

6.24e-0519518335a5302b8b3e76bc92dc38979400c979f0e86550
ToppCellmedial-Hematologic-Myeloid_Dendritic_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RAB6D NR4A3 ST14

6.24e-05195183c0d1ecb378bb482a8e08d7065fcca07a65687dac
ToppCellControl-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class

AMPD3 TNS3 PRKAG2

6.33e-05196183e2c2a30fa3ee3034fbde5335be169e880dde622d
ToppCellnucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

AMPD3 TNS3 PRKAG2

6.43e-05197183304044ace926943b8eb588f686ecbe5d1689a809
ToppCellnucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

AMPD3 TNS3 PRKAG2

6.43e-051971836f41c8f815851968849428ec92c16745bd01a3fb
ToppCellCOVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type

AMPD3 TNS3 PRKAG2

6.43e-051971833912301018d0863144dcfac8d1fa8adc081748d7
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ST14 UBR4 PRKAG2

6.62e-05199183379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCellIPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

AMPD3 TNS3 PRKAG2

6.62e-051991833c2b362d5e824e1a04830e70352f8818de984174
ToppCellCOPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class

AMPD3 TNS3 PRKAG2

6.62e-051991834b9c53fb4f44190d2f6ad4d52b13be01ebe4955e
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NR4A3 ST14 UBR4

6.72e-0520018374ceebee9af63f8b3ec5857eff1b662752bc3862
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related|GW09 / Sample Type, Dataset, Time_group, and Cell type.

CPEB2 SBNO2

6.06e-049118225197fde8b9bdaf1e28add695d13aff3ff52d86e
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related-Oligodendrocyte/OPC|GW09 / Sample Type, Dataset, Time_group, and Cell type.

CPEB2 SBNO2

6.06e-0491182ed4a48e5e5f5d8aadbc7b1b8d84a5f6363a08b85
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TNS3 NOBOX

1.29e-03133182f303ab771482281d8793974f9f5279cee09431fe
ToppCellRA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

NR4A3 PRKAG2

1.38e-031381825a713f24f633de463ef47ca37fbb2bb60c7fdb77
ToppCellParenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

CPEB2 ZNF462

1.44e-03141182dcc56aef1b31bfe0de84cb0b5c77d242681cf19c
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

ZNF462 NR4A3

1.51e-0314418238ff324366ad5be626e3657c1e33277fc36ddd4c
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

UBR4 TCF12

1.61e-03149182768877bade04ca0321593b8470b5011ad8270431
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TNS3 NOBOX

1.65e-0315118216fc903fc71e25717b9908416f0bcd29c0a65a61
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells)

ST14 TNS3

1.67e-03152182f717aae4882e9b67e5e40f4ef5b0d35f74a89165
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NR4A3 ST14

1.70e-03153182099382241971412f84b6feefb897360a74a41143
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

CPEB2 NR4A3

1.74e-03155182335cd798afbaa0a3a3e1dc558a81cfa32da48983
ToppCellEntopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

NR4A3 SBNO2

1.76e-031561825df19a235843829f5a1a90ca21b0964ef8b4e115
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CPEB2 ST14

1.76e-03156182fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e
ToppCellEntopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

NR4A3 SBNO2

1.76e-03156182029ba0832ee9c4a2c85620e4df2260e02d86b45c
ToppCelldroplet-Liver-Npc-21m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A3 SBNO2

1.78e-03157182264b22d0ffc43049161843bb55d2eccbf5fca575
ToppCelldroplet-Liver-Npc-21m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A3 SBNO2

1.78e-0315718267945d37027be62c880d3072afa7ca7e97c76c20
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells)

CPEB2 ST14

1.81e-031581820559cc032d0b518bb9e55aa3495f5573bd8e87dd
ToppCell10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue

ZNF462 ST14

1.88e-031611822f068ee643de2f647c289779a6624265ab9a749b
ToppCellP07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

HIVEP3 TNS3

1.88e-03161182b19f82dd98a3064581793711bb70373f18abecd9
ToppCell343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

HIVEP3 AMPD3

1.92e-031631820ab043b68e8739adcedda01165a3758cd0d22728
ToppCellInfluenza_Severe-cDC|World / Disease group and Cell class

NR4A3 ST14

1.94e-03164182c984228f73b9aa1aaf948541f64f41ed874770cd
ToppCellBAL-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters

ZNF462 AGFG2

1.94e-031641824bd9629d054545d1e3f9e5c127b5ac2388637106
ToppCellIonocyte-iono-3|World / Class top

ZNF462 AGFG2

1.99e-031661829c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCelldroplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF462 HIVEP3

1.99e-0316618235db3022c33d6f8bb6587d9eec89a7cccb70271a
ToppCellnormal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass

NR4A3 AMPD3

1.99e-0316618207b498eb341abec02a3ccaae320bdbb5cd6883c5
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

HIVEP3 NR4A3

2.09e-03170182ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TNS3 NOBOX

2.09e-031701825d5f208682be21ed58320f5fc083a7898f8712da
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP3 AMPD3

2.14e-031721823f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCellfacs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A3 SBNO2

2.14e-031721827c085c02b59e24e2a2cd393b5e692f9fb19257fe
ToppCellfacs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A3 SBNO2

2.14e-03172182c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f
ToppCell15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class

TNS3 ATN1

2.18e-03174182fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCellControl-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class

AMPD3 ST14

2.18e-031741824c64ff5666812fb4efa440ba4faeca51d916d68e
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HIVEP3 TNS3

2.23e-03176182cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF462 TNS3

2.23e-03176182327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCellPND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

AGFG2 AMPD3

2.23e-0317618290f8bb11f339f67f08692a0c33dd420f5cda2861
ToppCellmetastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass

NR4A3 ST14

2.26e-0317718243e1d0d3cf8f0c02e67d91f8dd1761df23d59e07
ToppCellControl-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class

AMPD3 ST14

2.26e-03177182470f54fe2b21c7350ea471e02039461a3808f700
ToppCellnormal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass

NR4A3 AMPD3

2.28e-03178182b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9
ToppCellCOPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class

HIVEP3 NR4A3

2.31e-0317918229b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCellE15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

HIVEP3 TNS3

2.31e-03179182b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCellBAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HIVEP3 AMPD3

2.31e-031791822fca4117c58824562ec80c7713fe15689a28efb3
ToppCellBAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HIVEP3 AMPD3

2.31e-03179182898425fa81526a2e00fca7a25085229ff1f31069
ToppCellBAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

HIVEP3 AMPD3

2.33e-03180182dcec59d66995f701d816eaeea3ed1439a2f71b73
ToppCellBAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

HIVEP3 AMPD3

2.33e-03180182f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725
ToppCellMatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4)

HIVEP3 TNS3

2.33e-03180182adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCellnormal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

ZNF462 AGFG2

2.33e-03180182a0b35067b6f2dbd8145da8bab760e9f650f045b0
ToppCellControl-Myeloid-MoAM2|Control / Disease group,lineage and cell class （2021.01.30）

HIVEP3 AMPD3

2.33e-0318018238892483a6a5388765aec87f0119c0b9bb5c7cbd
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NR4A3 ST14

2.36e-03181182c8286a7ac8e3cc5aa7e92b043a08435294ea686f
ToppCellcritical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ZNF462 RAB6C

2.36e-03181182f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCellE18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass

HIVEP3 TNS3

2.39e-03182182ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A3 ST14

2.39e-03182182ccfee33de0faebbe69099d4ff3c3971f6a708b99
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.39e-031821823cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.39e-031821828a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NR4A3 ST14

2.39e-031821821d37c486173cc4629842893ddd5033987c04086f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.39e-031821825d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NR4A3 ST14

2.39e-03182182aef67bdc6937b315522d39959e26c9b0acf7ab52
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.39e-03182182831b5ce46b41efe01c4db6016c2f43148611373d
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF462 TNS3

2.39e-031821825e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NR4A3 ST14

2.39e-03182182087c9f88daf08f5d688b728c2386f91f210d2255
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.39e-03182182e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.39e-03182182a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF462 TNS3

2.41e-03183182738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ST14 PRKAG2

2.41e-03183182ff751a97466807bf04b5a0740138c61e298cd1fc
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AGFG2 AMPD3

2.41e-03183182262387ee8d43b96e5f1a77c75124459a506a6172
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AGFG2 AMPD3

2.41e-03183182c85a707acbcb582912e8ac080a36d05f91cfd7a2
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HIVEP3 AMPD3

2.44e-03184182857ca1fc4de07b300839b22924211dc624453841
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NR4A3 AMPD3

2.44e-031841820a26bcc6610f756939e32a4d6dfeebcbf3a1db86
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.46e-03185182fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.46e-03185182efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.46e-031851827aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NR4A3 AMPD3

2.46e-03185182fec16a5e527fdef32d25957451b6e8ee9796cafd
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 TNS3

2.46e-031851822e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCellpdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CPEB2 TNS3

2.46e-031851821d874608aa2062024323512f68889219471b2f00
ToppCellLPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HIVEP3 NR4A3

2.46e-03185182a72ccb147ca505880e2da8f6a70b9d570464a691
ToppCellP03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

HIVEP3 TNS3

2.46e-03185182a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCelldroplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A3 ST14

2.49e-031861828eafd4bea692f7ef33de27dd53f9d1fe67deaad8
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A3 ATN1

2.49e-03186182bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ZNF462 AMPD3

2.52e-03187182a6a112689d1c9049f57935ad9d2f4955538427de
ToppCellMesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class

HIVEP3 TNS3

2.52e-03187182e899b906409f3fad69cb3d3c6432c3fd862ae3c1
ToppCellPBMC-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters

NR4A3 ATN1

2.52e-031871820afef5baf3752314dbfb024790347d5e51f9b84b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CPEB2 HIVEP3

2.52e-0318718287b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CPEB2 HIVEP3

2.52e-0318718242a1267bfc27b4460b8409ada580a87c4385841c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CPEB2 HIVEP3

2.52e-0318718264afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF462 TNS3

2.54e-0318818263a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
DrugFusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A

HIVEP3 AMPD3 SBNO2 PRKAG2

1.54e-051981842647_UP
DrugPerhexiline maleate [6724-53-4]; Up 200; 10.2uM; PC3; HT_HG-U133A

AGFG2 HIVEP3 AMPD3 ATN1

1.57e-051991845081_UP
DrugN-acetylcysteamine

NR4A3 ATN1

1.23e-0421182CID000014484
Drug15d-PGJ2; Up 200; 10uM; HL60; HT_HG-U133A

NR4A3 UBR4 PRKAG2

2.77e-041641836190_UP
DrugDinoprost trometamol [38362-01-5]; Up 200; 8.4uM; HL60; HT_HG-U133A

NR4A3 UBR4 PRKAG2

2.87e-041661832446_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

HIVEP3 TNS3 SBNO2

2.92e-041671833979_DN
DrugEMCs

NR4A3 TCF12

3.26e-0434182CID005091655
DrugVigabatrin [60643-86-9]; Up 200; 31uM; HL60; HT_HG-U133A

NR4A3 UBR4 PRKAG2

3.29e-041741832452_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

NR4A3 AMPD3 PRKAG2

3.40e-041761832666_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

NR4A3 AMPD3 PRKAG2

3.46e-041771832678_UP
Drughydroxyethyl acrylate

ST14 TCF12

3.66e-0436182CID000013165
DrugEtilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; HL60; HT_HG-U133A

NR4A3 AMPD3 UBR4

3.69e-041811832930_UP
DrugHexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A

NR4A3 SBNO2 PRKAG2

3.94e-041851832457_UP
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A

NR4A3 ATN1 PRKAG2

4.00e-041861832684_UP
Drug2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A

HIVEP3 SBNO2 ATN1

4.13e-04188183345_DN
DrugRolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A

NR4A3 ST14 SBNO2

4.19e-041891833072_UP
DrugFenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; PC3; HT_HG-U133A

HIVEP3 TNS3 SBNO2

4.46e-041931836331_DN
DrugNorgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A

AGFG2 UBR4 ATN1

4.46e-041931833708_UP
Drug0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A

ST14 SBNO2 ATN1

4.52e-041941834331_DN
DrugAlthiazide [5588-16-9]; Down 200; 10.4uM; HL60; HT_HG-U133A

HIVEP3 SBNO2 PRKAG2

4.52e-041941832527_DN
DrugMinocycline hydrochloride [13614-98-7]; Up 200; 8uM; PC3; HT_HG-U133A

HIVEP3 AMPD3 SBNO2

4.52e-041941835077_UP
DrugPNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP3 SBNO2 ATN1

4.52e-041941834291_DN
DrugAtractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A

HIVEP3 AMPD3 ATN1

4.59e-041951833695_DN
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A

NR4A3 UBR4 ATN1

4.59e-041951836183_UP
DrugMephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A

AGFG2 HIVEP3 ATN1

4.59e-041951833580_DN
DrugDicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A

HIVEP3 SBNO2 ATN1

4.59e-041951833941_DN
DrugMecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A

AMPD3 ST14 SBNO2

4.59e-041951833525_DN
DrugAtovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A

HIVEP3 SBNO2 ATN1

4.59e-041951834201_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A

HIVEP3 SBNO2 ATN1

4.59e-041951834235_DN
Drug(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A

AGFG2 UBR4 ATN1

4.59e-041951833789_UP
DrugFlorfenicol [73231-34-2]; Down 200; 11.2uM; HL60; HT_HG-U133A

HIVEP3 AMPD3 ST14

4.59e-041951833083_DN
DrugBoldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A

HIVEP3 AMPD3 SBNO2

4.66e-041961834122_DN
DrugMafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A

AGFG2 ST14 SBNO2

4.66e-041961835079_DN
Drug0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP3 ST14 ATN1

4.66e-041961834292_DN
DrugMeglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A

AMPD3 SBNO2 ATN1

4.66e-041961836445_DN
DrugPepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A

ST14 SBNO2 ATN1

4.66e-041961834206_DN
DrugLoracarbef [121961-22-6]; Down 200; 10.8uM; PC3; HT_HG-U133A

ST14 SBNO2 ATN1

4.66e-041961835073_DN
DrugAsiaticoside [16830-15-2]; Up 200; 4.2uM; HL60; HT_HG-U133A

HIVEP3 NR4A3 UBR4

4.66e-041961832943_UP
DrugPralidoxime chloride [51-15-0]; Down 200; 23.2uM; HL60; HT_HG-U133A

NR4A3 SBNO2 UBR4

4.66e-041961833066_DN
DrugTenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A

AGFG2 AMPD3 ATN1

4.66e-041961834182_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A

AGFG2 AMPD3 ATN1

4.73e-041971832324_DN
DrugAjmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A

HIVEP3 SBNO2 ATN1

4.73e-041971832898_UP
DrugAlclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A

HIVEP3 UBR4 ATN1

4.73e-041971836094_UP
DrugAminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A

HIVEP3 AMPD3 SBNO2

4.73e-041971836453_DN
DrugSolasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A

SBNO2 ATN1 PRKAG2

4.73e-041971833924_DN
DrugMyosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A

HIVEP3 AMPD3 ATN1

4.73e-041971836055_UP
DrugClonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A

HIVEP3 SBNO2 ATN1

4.73e-041971836814_UP
DrugNU1025; Up 200; 100uM; MCF7; HG-U133A

AGFG2 HIVEP3 SBNO2

4.73e-04197183313_UP
DrugBacitracin [1405-87-4]; Up 200; 2.8uM; HL60; HT_HG-U133A

ST14 SBNO2 ATN1

4.80e-041981833109_UP
DrugIfosfamide [3778-73-2]; Up 200; 15.4uM; PC3; HT_HG-U133A

AGFG2 SBNO2 ATN1

4.80e-041981835805_UP
DrugNalidixic acid sodium salt hydrate; Up 200; 14.6uM; HL60; HT_HG-U133A

HIVEP3 AMPD3 PRKAG2

4.80e-041981832336_UP
DrugClozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A

AGFG2 SBNO2 ATN1

4.80e-041981832644_UP
DrugTolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A

HIVEP3 SBNO2 ATN1

4.80e-041981834805_DN
DrugEthisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A

AGFG2 HIVEP3 ATN1

4.80e-041981833864_UP
DrugOrphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A

HIVEP3 ST14 ATN1

4.80e-041981833883_DN
DrugTimolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A

AGFG2 HIVEP3 ATN1

4.80e-041981835645_UP
DrugAmrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A

AMPD3 ST14 SBNO2

4.80e-041981832724_DN
Drugnordihydroguaiaretic acid; Up 200; 1uM; ssMCF7; HG-U133A

HIVEP3 SBNO2 ATN1

4.80e-04198183524_UP
DrugPhenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A

AGFG2 HIVEP3 SBNO2

4.80e-041981832319_UP
DrugSC-58125; Up 200; 10uM; MCF7; HG-U133A

AGFG2 AMPD3 ATN1

4.87e-04199183254_UP
DrugS(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A

NR4A3 SBNO2 UBR4

4.87e-041991833082_DN
DrugMebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A

RNF38 SBNO2 ATN1

4.87e-041991834795_DN
DrugGriseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A

HIVEP3 AMPD3 ATN1

4.87e-041991833664_DN
DrugOndansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; HL60; HT_HG-U133A

NR4A3 UBR4 ATN1

4.87e-041991836153_UP
Drugretinoic acid; Up 200; 1uM; PC3; HG-U133A

NR4A3 AMPD3 PRKAG2

4.87e-04199183447_UP
DrugDipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A

HIVEP3 NR4A3 ATN1

4.87e-041991833835_UP
DrugPiretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A

AGFG2 HIVEP3 SBNO2

4.87e-041991836828_UP
DrugMethylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; PC3; HT_HG-U133A

HIVEP3 AMPD3 ATN1

4.87e-041991833994_DN
DrugICI 182,780; Up 200; 1uM; ssMCF7; HG-U133A

AGFG2 NR4A3 SBNO2

4.87e-04199183523_UP
DrugAmiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; PC3; HT_HG-U133A

HIVEP3 AMPD3 ATN1

4.87e-041991834000_DN
Drug2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A

HIVEP3 SBNO2 ATN1

4.87e-04199183346_DN
DrugMepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A

HIVEP3 AMPD3 ATN1

4.87e-041991836024_UP
DrugLorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; HL60; HT_HG-U133A

AGFG2 ST14 SBNO2

4.94e-042001833079_UP
DrugChlorthalidone [77-36-1]; Up 200; 11.8uM; PC3; HT_HG-U133A

HIVEP3 ST14 SBNO2

4.94e-042001837152_UP
DrugAlfadolone acetate [23930-37-2]; Up 200; 10.2uM; HL60; HT_HG-U133A

AGFG2 NR4A3 ST14

4.94e-042001833127_UP
DrugPhenethicillin potassium salt [132-93-4]; Up 200; 10uM; HL60; HT_HG-U133A

AGFG2 ST14 ATN1

4.94e-042001832542_UP
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A

NR4A3 AMPD3 ATN1

4.94e-042001834109_UP
DrugEtifenin [63245-28-3]; Up 200; 12.4uM; HL60; HT_HG-U133A

NR4A3 SBNO2 UBR4

4.94e-042001832477_UP
DrugThonzonium bromide [553-08-2]; Down 200; 6.8uM; HL60; HT_HG-U133A

NR4A3 AMPD3 ST14

4.94e-042001833080_DN
DrugBoldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A

AGFG2 ST14 UBR4

4.94e-042001832148_UP
Drugpirimicarb

NR4A3 ATN1

7.07e-0450182CID000031645
DiseaseExtraskeletal Myxoid Chondrosarcoma

NR4A3 TCF12

3.51e-065182C1275278
DiseaseCraniosynostosis

ZNF462 TCF12

6.63e-0520182C0010278
Diseaseretinal degeneration (implicated_via_orthology)

RAB6D RAB6C

1.84e-0433182DOID:8466 (implicated_via_orthology)
Diseaseorofacial cleft, sex interaction measurement

ST14 TNS3

1.25e-0386182EFO_0008343, MONDO_0000358
Diseasekeratinocyte carcinoma

TNS3 SBNO2

2.33e-03118182EFO_0010176
Diseasecreatinine measurement

ST14 SBNO2 TCF12 PRKAG2

2.69e-03995184EFO_0004518
Diseasewhite matter integrity

AMPD3 PRKAG2

2.81e-03130182EFO_0004641
Diseasehematocrit

ZNF462 AGFG2 AMPD3 PRKAG2

2.85e-031011184EFO_0004348
DiseaseGlobal developmental delay

ZNF462 ATN1

2.94e-03133182C0557874
Diseaseintraocular pressure measurement

HIVEP3 TCF12 PRKAG2

3.43e-03509183EFO_0004695
Diseasecolorectal cancer

AMPD3 TNS3 SBNO2

5.54e-03604183MONDO_0005575
Diseasebasal cell carcinoma

TNS3 SBNO2

5.84e-03189182EFO_0004193
Diseaseopen-angle glaucoma

TCF12 PRKAG2

5.96e-03191182EFO_0004190
Diseasetestosterone measurement

AGFG2 AMPD3 TNS3 TCF12

6.53e-031275184EFO_0004908
Diseasepulse pressure measurement

HIVEP3 AMPD3 TNS3 PRKAG2

8.87e-031392184EFO_0005763
Diseasealopecia

ZNF462 TCF12

9.32e-03241182MONDO_0004907

Protein segments in the cluster

PeptideGeneStartEntry
KTSPGSPKTVFPFSY

PRKAG2

96

Q9UGJ0
APAPPMRFPYSSSSS

ATN1

366

P54259
ATSLPTPAPYAMPEF

AMPD3

116

Q01432
PMSSSTLPQKPPYSF

RAB6C

211

Q9H0N0
PMSSSTLPQKPPYSF

RAB6D

211

Q53S08
PYLPTFPFSMPSSLT

NOBOX

536

O60393
YPSPKPPTSMFASTF

TCF12

211

Q99081
LPSSMNPAFFPSFSP

CPEB2

16

Q7Z5Q1
TSMYFKQSPPSTPTT

NR4A3

131

Q92570
FDYTSASPAPSPPMR

RNF38

71

Q9H0F5
PPYPAFSSDSRPFMS

SBNO2

46

Q9Y2G9
MCSTPAFPVSPETPY

TNS3

841

Q68CZ2
FMTGPSSSPFASKPP

AGFG2

461

O95081
MASPFSITSKTYPPD

TAS2R5

236

Q9NYW4
MRFTTPGFPDSPYPA

ST14

226

Q9Y5Y6
PSFLPMPYPTSSALS

HIVEP3

1221

Q5T1R4
PNSSASKFSPMSYPQ

ZNF462

331

Q96JM2
KPHTTSSPPDMSPFF

UBR4

3126

Q5T4S7